English(EN) DrugReason: Dynamic Multi-View Reasoning over Knowledge Graph and Language Evidence for Drug Repurposing

新框架DrugReason结合知识图谱和LLM进行药物再利用

作者 PulseAugur 编辑部 · [1 个来源] · 2026-09-10 04:00

研究人员开发了DrugReason，一个旨在通过整合知识图谱推理和大型语言模型（LLM）见解来增强药物再利用的新型框架。这种方法解决了单独使用任一方法的局限性，因为知识图谱可能受限于现有结构，而LLM在没有事实依据的情况下可能会产生幻觉。DrugReason自适应地将推理路径路由到专业专家，并使用跨专家蒸馏进行知识共享，在PharmaDB、DDInter和DrugBank等数据集上展示了改进的性能。 AI

影响这项研究可以通过提高识别现有化合物新治疗用途的准确性和可解释性来加速药物发现。

排序理由该项目是一篇学术论文，详细介绍了一种用于药物再利用的新计算框架。[lever_c_demoted from research: ic=1 ai=1.0]

在 arXiv cs.AI 阅读 →

AI 生成摘要 · Google Gemini · 来自 1 个来源。我们如何撰写摘要 →

本文如何被排名

Signal score: 13 / 100; Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket: Tool; 该项目是一篇学术论文，详细介绍了一种用于药物再利用的新计算框架。[lever_c_demoted from research: ic=1 ai=1.0]
Source corroboration: Single-source cluster; Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics: paper, other; Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance: High; Clearly on-topic for AI-industry coverage.
Story freshness: Breaking (< 6h); Fresh story with cross-source coverage still developing. Ranking may shift as more sources report.

完整方法见我们的编辑标准。

报道来源 [1]

arXiv cs.AI TIER_1 English(EN) · Zijie Liu, Hongxuan Li, Zhen Tan, Jinhao Duan, Baixiang Huang, Zunpeng Liu, Kai Shu, Tianlong Chen · 2026-09-10 04:00

DrugReason：基于知识图谱和语言证据的动态多视图推理用于药物再利用

arXiv:2609.06779v1 Announce Type: cross Abstract: Drug repurposing aims to identify new therapeutic uses for existing compounds and, compared with de novo drug discovery, offers a faster and more cost-effective path to clinical translation. However, the space of candidate drug-di…

本文如何被排名

报道来源 [1]

DrugReason：基于知识图谱和语言证据的动态多视图推理用于药物再利用

相关实体

相关话题